Clinical Trials Browser

Phase 2 × Esophageal Squamous Cell Carcinoma × Gemcitabine × Clear all

NCT01469598 2015-12-29

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma

NCT00012363 2012-06-14

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms